Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZEN003694 with Chemotherapy in NUT Carcinoma
NCT05019716Phase 2Recruiting
- Sponsor
- National Cancer Institute
- Start
- Jul 2022
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZEN3694 in NUT carcinoma (NC), sponsored by National Cancer Institute. Started Jul 2022; status: recruiting.
02
Drugs
ZEN3694
03
Conditions
NUT carcinoma (NC)
Beyond the preview
Go deeper on NCT05019716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05019716.